Market Tracker

09/16 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.25
Data as of Sep 16
 +0.12 / +1.48%
Today’s Change
5.84
Today|||52-Week Range
11.47
+9.42%
Year-to-Date

Today’s Trading

Previous close8.13
Today’s open8.13
Day’s range7.94 - 8.29
Volume248,824
Average volume (3 months)450,567
Market cap$348.9M
Dividend yield--
Data as of 3:59pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+95.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book9.71

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...+0.05+0.97%
ECYTEndocyte Inc-0.23-2.82%
SCLNSciClone Pharmaceuti...+0.15+2.13%
DVAXDynavax Technologies...-0.03-2.17%
Data as of 3:59pm ET, 09/16/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.33
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts